Correlation Between Radiopharm Theranostics and Biocardia

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Radiopharm Theranostics and Biocardia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Radiopharm Theranostics and Biocardia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Radiopharm Theranostics Limited and Biocardia, you can compare the effects of market volatilities on Radiopharm Theranostics and Biocardia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Radiopharm Theranostics with a short position of Biocardia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Radiopharm Theranostics and Biocardia.

Diversification Opportunities for Radiopharm Theranostics and Biocardia

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between Radiopharm and Biocardia is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Radiopharm Theranostics Limite and Biocardia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biocardia and Radiopharm Theranostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Radiopharm Theranostics Limited are associated (or correlated) with Biocardia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biocardia has no effect on the direction of Radiopharm Theranostics i.e., Radiopharm Theranostics and Biocardia go up and down completely randomly.

Pair Corralation between Radiopharm Theranostics and Biocardia

Given the investment horizon of 90 days Radiopharm Theranostics Limited is expected to generate 0.77 times more return on investment than Biocardia. However, Radiopharm Theranostics Limited is 1.3 times less risky than Biocardia. It trades about -0.04 of its potential returns per unit of risk. Biocardia is currently generating about -0.05 per unit of risk. If you would invest  560.00  in Radiopharm Theranostics Limited on August 25, 2025 and sell it today you would lose (105.00) from holding Radiopharm Theranostics Limited or give up 18.75% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Radiopharm Theranostics Limite  vs.  Biocardia

 Performance 
       Timeline  
Radiopharm Theranostics 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Radiopharm Theranostics Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Biocardia 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Biocardia has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in December 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Radiopharm Theranostics and Biocardia Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Radiopharm Theranostics and Biocardia

The main advantage of trading using opposite Radiopharm Theranostics and Biocardia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Radiopharm Theranostics position performs unexpectedly, Biocardia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biocardia will offset losses from the drop in Biocardia's long position.
The idea behind Radiopharm Theranostics Limited and Biocardia pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data